Alpha 1 Antitrypsin Deficiency Aatd Emphysema clinical trials

Explore recruiting alpha 1 antitrypsin deficiency aatd emphysema clinical trials.

Recruiting alpha 1 antitrypsin deficiency aatd emphysema studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Alpha 1 Antitrypsin Deficiency Aatd Emphysema trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2, Single-Arm, Open-Label Extension Study, Evaluating the Long-Term Safety and Clinical Efficacy of SAR447537 (INBRX-101) in Adults with Alpha-1 Antitrypsin Deficiency (AATD) Emphysema

Spain, Sweden, Denmark, Poland, Ireland

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2, Double-blind, Randomized, Active-control, Parallel Group Study to Assess the Pharmacokinetics, Pharmacodynamics, Immunogenicity, and safety of SAR447537 (INBRX-101) Compared to Plasma Derived Apha1-Proteinase Inhibitor (A1PI) Augmentation Therapy in Adults with Alpha-1 Antitrypsin Deficiency (AATD) Emphysema

Denmark, Sweden, Ireland, Spain, Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

Alpha 1 Antitrypsin Deficiency Aatd Emphysema trials by city

Alpha 1 Antitrypsin Deficiency Aatd Emphysema in Toronto Alpha 1 Antitrypsin Deficiency Aatd Emphysema in Vancouver Alpha 1 Antitrypsin Deficiency Aatd Emphysema in Montreal Alpha 1 Antitrypsin Deficiency Aatd Emphysema in Calgary Alpha 1 Antitrypsin Deficiency Aatd Emphysema in Edmonton Alpha 1 Antitrypsin Deficiency Aatd Emphysema in Ottawa Alpha 1 Antitrypsin Deficiency Aatd Emphysema in Winnipeg Alpha 1 Antitrypsin Deficiency Aatd Emphysema in Quebec City Alpha 1 Antitrypsin Deficiency Aatd Emphysema in Hamilton Alpha 1 Antitrypsin Deficiency Aatd Emphysema in Kitchener Alpha 1 Antitrypsin Deficiency Aatd Emphysema in London Alpha 1 Antitrypsin Deficiency Aatd Emphysema in Halifax Alpha 1 Antitrypsin Deficiency Aatd Emphysema in New York Alpha 1 Antitrypsin Deficiency Aatd Emphysema in Los Angeles Alpha 1 Antitrypsin Deficiency Aatd Emphysema in Chicago Alpha 1 Antitrypsin Deficiency Aatd Emphysema in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease